ns 2028 has been researched along with oxadiazoles in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (16.67) | 18.2507 |
2000's | 13 (43.33) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Axelsson, O; Bang, L; Busse, R; Drejer, J; Moldt, P; Mülsch, A; Nielsen-Kudsk, JE; Olesen, SP | 1 |
Brüne, B; Callsen, D; Pfeilschifter, J | 1 |
Aldershvile, J; Bauersachs, J; Busse, R; Fleming, I; Schäfer, A; Scholz, D | 1 |
Aldershvile, J; Bang, L; Boesgaard, S; Gruhn, N; Nielsen-Kudsk, JE; Olesen, SP; Theilgaard, SA | 1 |
Aldershvile, J; Bang, L; Boesgaard, S; Nielsen-Kudsk, JE; Vejlstrup, NG | 1 |
Brüne, B; Fandrey, J; Sandau, KB | 1 |
Kellum, JM; Stoner, MC | 1 |
Trakranrungsie, N; Will, JA | 1 |
Fujimura, S; Hisa, H; Nakamura, K; Satoh, S; Suzuki-Kusaba, M; Tanioka, H; Yoshida, M | 1 |
Furneaux, H; Kloss, S; Mülsch, A | 1 |
Chan, SL; Fiscus, RR | 1 |
Busse, R; Fleming, I; Randriamboavonjy, V; Schrader, J | 1 |
Berg, A; Ericson, AC; Grenegård, M; Redéen, S; Sjöstrand, SE | 1 |
Fung, YK; Liu, X; Pahan, K; Roy, A | 1 |
Jang, Y; Mueller, RA; Norfleet, EA; Wang, H; Xi, J; Xu, Z | 1 |
Detmar, M; Drinnenberg, I; Huggenberger, R; Kajiya, K; Ma, B | 1 |
Haramis, G; Koutsilieris, M; Papapetropoulos, A; Pyriochou, A; Roussos, C; Zhou, Z | 1 |
Dombkowski, RA; Gao, Y; Motterlini, R; Olson, KR; Whitfield, NL | 1 |
Filippi, S; Giannis, A; Loutrari, H; Morbidelli, L; Papapetropoulos, A; Pyriochou, A; Roussos, C; Stössel, A; Vasileiadis, I; Waltenberger, J; Zhou, Z; Ziche, M | 1 |
Au, AL; Félétou, M; Kwan, YW; Leung, SW; Liang, CF; Man, RY; Ng, KF; Vanhoutte, PM | 1 |
Ahtesham, AK; Akaike, T; Ida, T; Ihara, H; Kasamatsu, S; Kunieda, K; Okamoto, T; Sawa, T | 1 |
Buck, J; Hess, KC; Levin, LR; Ramos-Espiritu, LS | 1 |
Hoffmann, C; Hoffmann, LS; Keim, Y; Schmidt, HH; Schmidt, PM; Stasch, JP | 1 |
Meng, Z; Zhang, Q | 1 |
Bilzer, M; Gerbes, AL; Gmelin, L; Göke, B; Steib, CJ | 1 |
Friebe, A; Gambaryan, S; Groneberg, D; Lies, B | 1 |
Fang, F; Liu, X; Pan, M; Qu, J; Tao, Y; Wu, H; Yan, T; Zhou, X | 1 |
Artinian, L; Estes, S; Rehder, V | 1 |
Chuang, VTG; Ikeda, M; Ikeda, T; Ishida, T; Ishima, Y; Kinoshita, R; Maruyama, T; Otagiri, M; Watanabe, H | 1 |
Krutsenko, Y; Lezgyieva, K; Martin, E; Sharina, I | 1 |
30 other study(ies) available for ns 2028 and oxadiazoles
Article | Year |
---|---|
Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Topics: Animals; Cattle; Cells, Cultured; Cerebellum; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Guinea Pigs; Heme; Humans; In Vitro Techniques; Kinetics; Male; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Oxadiazoles; Oxazines; Rabbits; Solubility; Spectrophotometry; Structure-Activity Relationship; Swine; Umbilical Veins | 1998 |
Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
Topics: Acetylcysteine; Animals; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cyclic GMP; Enzyme Activation; Free Radical Scavengers; Glomerular Mesangium; Glutathione; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molsidomine; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Onium Compounds; Oxadiazoles; Oxazines; Phosphorylation; Protein Processing, Post-Translational; Protein Tyrosine Phosphatases; Rats; S-Nitrosoglutathione; Second Messenger Systems | 1998 |
Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Animals; Aorta, Thoracic; Benzoquinones; Calcium; Calmodulin; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Female; Genistein; Hydroquinones; Imidazoles; In Vitro Techniques; Indoles; Isometric Contraction; Lactams, Macrocyclic; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Oxadiazoles; Oxazines; Quinones; Rabbits; Rifabutin; Staurosporine | 1999 |
Vascular smooth muscle contraction is an independent regulator of endothelial nitric oxide production.
Topics: Animals; Endothelium, Vascular; Enzyme Inhibitors; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Oxazines; Rats; Rats, Wistar; Vasomotor System | 1999 |
Nitroglycerin-mediated vasorelaxation is modulated by endothelial calcium-activated potassium channels.
Topics: Animals; Calcium; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Ion Channel Gating; Male; Nitroglycerin; Oxadiazoles; Oxazines; Peptides; Perfusion; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Regional Blood Flow; Regression Analysis; Swine; Vasodilator Agents | 1999 |
Accumulation of HIF-1alpha under the influence of nitric oxide.
Topics: Animals; Benzoates; Cell Hypoxia; Cell Line; Cobalt; Coculture Techniques; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glutathione; Guanylate Cyclase; Hydrazines; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Inflammation; Kidney Tubules, Proximal; Macrophage Activation; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Nitroso Compounds; Nuclear Proteins; Oxadiazoles; Oxazines; S-Nitrosoglutathione; Spermine; Swine; Transcription Factors | 2001 |
Both serotonin and a nitric-oxide donor cause chloride secretion in rat colonocytes by stimulating cGMP.
Topics: Animals; Chlorides; Colon; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Male; Nitric Oxide Donors; Oxadiazoles; Oxazines; Polyamines; Rats; Rats, Sprague-Dawley; Serotonin | 2001 |
Comparative vasodilation of peroxynitrite and 3-morpholinosydnonimine.
Topics: Adenine; Animals; Benzoates; Cattle; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Mammary Arteries; Molsidomine; Muscle Relaxation; Muscle, Smooth, Vascular; Oxadiazoles; Oxazines; Oxidants; Peroxynitrous Acid; Vasodilation; Vasodilator Agents | 2001 |
Facilitatory role of NO in neural norepinephrine release in the rat kidney.
Topics: Animals; Benzoates; Cyclic GMP; Electric Stimulation; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indazoles; Kidney; Male; Nervous System; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Norepinephrine; Oxadiazoles; Oxazines; Perfusion; Pressure; Rats; Rats, Wistar | 2002 |
Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta.
Topics: 3' Untranslated Regions; Animals; Antigens, Surface; Aorta; Base Sequence; Blotting, Northern; Blotting, Western; Cell Nucleus; Cells, Cultured; Dactinomycin; Down-Regulation; ELAV Proteins; ELAV-Like Protein 1; Enzyme Activators; Guanylate Cyclase; Indazoles; Male; Molecular Sequence Data; Muscle, Smooth; Nucleic Acid Synthesis Inhibitors; Oxadiazoles; Oxazines; Poly A; Protein Binding; Protein Structure, Tertiary; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering; Soluble Guanylyl Cyclase; Time Factors; Transcription, Genetic; Transfection | 2003 |
Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG.
Topics: Animals; Apoptosis; Carbazoles; Cell Line, Transformed; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA; DNA Fragmentation; Enzyme Inhibitors; Epithelial Cells; Female; Guanylate Cyclase; Indoles; Oxadiazoles; Oxazines; Quinoxalines; Signal Transduction; Uterus | 2003 |
Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway.
Topics: Adenosine; Adenosine Triphosphate; Blood Platelets; Carbazoles; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; Indoles; Insulin; Nitric Oxide; Oxadiazoles; Oxazines; Protein Kinase Inhibitors; Serotonin; Vasodilation | 2004 |
Nitric oxide inhibits gastric acid secretion by increasing intraparietal cell levels of cGMP in isolated human gastric glands.
Topics: Adult; Cyclic GMP; Dibutyryl Cyclic GMP; Gastric Acid; Guanylate Cyclase; Histamine; Histamine Antagonists; Humans; Male; Nitric Oxide; Oxadiazoles; Oxazines; Parietal Cells, Gastric; S-Nitroso-N-Acetylpenicillamine | 2005 |
Up-regulation of microglial CD11b expression by nitric oxide.
Topics: Animals; CD11b Antigen; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microglia; Neurodegenerative Diseases; Nitric Oxide; Oxadiazoles; Oxazines; Up-Regulation | 2006 |
NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes.
Topics: Animals; Cells, Cultured; Chlorides; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Flavonoids; Guanylate Cyclase; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondria, Heart; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Oxazines; Oxidation-Reduction; Penicillamine; Phosphorylation; Quinoxalines; Rats; Signal Transduction; Zinc; Zinc Compounds | 2007 |
Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation.
Topics: Cell Movement; Cell Proliferation; Cells, Cultured; Cyclic GMP; Edema; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Humans; Immunity, Cellular; Inflammation; Lymphatic Vessels; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Oxazines; Receptors, Cytoplasmic and Nuclear; S-Nitroso-N-Acetylpenicillamine; Soluble Guanylyl Cyclase | 2008 |
cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines.
Topics: Antineoplastic Agents; Caspase 3; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic GMP; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Humans; Male; Nitroprusside; Oxadiazoles; Oxazines; Prostatic Neoplasms; RNA Interference; Solubility | 2008 |
Effects of carbon monoxide on trout and lamprey vessels.
Topics: Animals; Aorta; Branchial Region; Carbon Monoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Hydrogen Sulfide; Muscle, Smooth, Vascular; Myography; Nitric Oxide; Nitroprusside; Norepinephrine; Oncorhynchus mykiss; Organometallic Compounds; Oxadiazoles; Oxazines; Petromyzon; Polarography; Potassium Channel Blockers; Potassium Chloride; Protoporphyrins; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.
Topics: Animals; Aorta; Capillary Permeability; Cell Division; Cell Movement; Cells, Cultured; Cornea; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Fibroblast Growth Factor 2; Guanylate Cyclase; Humans; Neovascularization, Physiologic; Oxadiazoles; Oxazines; p38 Mitogen-Activated Protein Kinases; Rabbits; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Umbilical Veins; Vascular Endothelial Growth Factor A; Vasodilation | 2010 |
Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle.
Topics: Animals; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Ion Channel Gating; Large-Conductance Calcium-Activated Potassium Channels; Muscle, Smooth, Vascular; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Oxazines; Patch-Clamp Techniques; Peptides; Swine; Vasodilation | 2010 |
Methodological proof of immunochemistry for specific identification of 8-nitroguanosine 3',5'-cyclic monophosphate formed in glia cells.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Blotting, Western; Cells, Cultured; Chromatography, Liquid; Cyclic GMP; Cytokines; Cytoprotection; Epitopes; Guanylate Cyclase; Immunohistochemistry; Lipopolysaccharides; Neuroglia; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Oxadiazoles; Oxazines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2011 |
The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells.
Topics: Animals; Blotting, Western; Cell Line; Cyclic AMP; Cyclic GMP; Enzyme Activators; Enzyme Inhibitors; Glucose; Guanylate Cyclase; Indazoles; Insulin-Secreting Cells; Mitogen-Activated Protein Kinases; Morpholines; Oxadiazoles; Oxazines; Phosphoric Diester Hydrolases; Pyrimidines; Quinoxalines; Rats; Transcription, Genetic | 2011 |
Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Benzoates; CHO Cells; Cricetinae; Cricetulus; Cyclic GMP; Cysteine; Enzyme Activation; Enzyme Activators; Fluorescence; Fluorescent Dyes; Guanylate Cyclase; Heme; Humans; Molecular Sequence Data; Mutation; Nitric Oxide; Oxadiazoles; Oxazines; Oxidation-Reduction; Protein Engineering; Receptors, Cytoplasmic and Nuclear; Rotenone; Signal Transduction; Soluble Guanylyl Cyclase; Spectrometry, Fluorescence | 2011 |
The inotropic effects of ammonia on isolated perfused rat hearts and the mechanisms involved.
Topics: Adenosine Triphosphatases; Ammonia; Ammonium Chloride; Animals; Cardiotonic Agents; Creatine Kinase; Cyclic GMP; Guanylate Cyclase; Heart; Heart Ventricles; Hydrogen-Ion Concentration; In Vitro Techniques; KATP Channels; L-Lactate Dehydrogenase; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Oxazines; Perfusion; Pressure; Rats; Signal Transduction; Small-Conductance Calcium-Activated Potassium Channels; Sodium Hydroxide; Solubility | 2011 |
Portal pressure regulation following Kupffer cell activation: control of prostaglandin production by heme oxygenases.
Topics: Animals; Carbon Monoxide; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Kupffer Cells; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Oxazines; Portal Pressure; Prostaglandins; Protoporphyrins; Rats; Rats, Sprague-Dawley | 2013 |
Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase.
Topics: Adult; Animals; Aorta; Cyclic GMP; Female; Guanylate Cyclase; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Oxazines; Signal Transduction | 2013 |
The role of cGMP in ocular growth and the development of form-deprivation myopia in guinea pigs.
Topics: Animals; Collagen; Conjunctiva; Cyclic GMP; Disease Progression; Eye; Guanylate Cyclase; Guinea Pigs; Injections; Myopia; Oxadiazoles; Oxazines; Radioimmunoassay; Retina; Sclera; Sensory Deprivation | 2013 |
Modulation of growth cone filopodial length by carbon monoxide.
Topics: Action Potentials; Animals; Calcium; Carbazoles; Carbon Monoxide; Enzyme Inhibitors; Ganglia, Invertebrate; Growth Cones; Heme Oxygenase-1; Neurons; Nitric Oxide; Organometallic Compounds; Oxadiazoles; Oxazines; Patch-Clamp Techniques; Pseudopodia; Quinoxalines; Signal Transduction; Snails; Time Factors | 2017 |
Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Colonic Neoplasms; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Resistance, Neoplasm; Drug Synergism; Drugs, Chinese Herbal; Humans; Hypoxia; Male; Mice, Inbred BALB C; Nitroso Compounds; Oxadiazoles; Oxazines; Phosphodiesterase 5 Inhibitors; Plant Extracts; Reactive Oxygen Species; Serum Albumin, Human; Soluble Guanylyl Cyclase; Vardenafil Dihydrochloride | 2017 |
Higher susceptibility to heme oxidation and lower protein stability of the rare α
Topics: Animals; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Genetic Variation; Heme; Humans; Moyamoya Disease; Oxadiazoles; Oxazines; Oxidation-Reduction; Protein Stability; Protein Structure, Secondary; Sf9 Cells; Soluble Guanylyl Cyclase | 2021 |